Serum levels of human immunodeficiency virus type 1 (HIV-1) RNA after seroconversion: A predictor of long-term mortality in HIV infection

被引:30
作者
Craib, KJP
Strathdee, SA
Hogg, RS
Leung, B
Montaner, JSG
OShaughnessy, MV
Schechter, MT
机构
[1] UNIV BRITISH COLUMBIA,FAC MED,BRITISH COLUMBIA CTR EXCELLENCE HIV AIDS,VANCOUVER,BC V6T 1Z3,CANADA
[2] UNIV BRITISH COLUMBIA,DEPT HLTH CARE & EPIDEMIOL,VANCOUVER,BC V6T 1Z3,CANADA
[3] UNIV BRITISH COLUMBIA,DEPT MED,VANCOUVER,BC V6T 1Z3,CANADA
[4] ST PAULS HOSP,VANCOUVER,BC V6Z 1Y6,CANADA
关键词
D O I
10.1086/517305
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A cohort of 79 homosexual men with documented dates of human immunodeficiency virus type 1 (HIV-1) seroconversion and baseline CD4 cell counts of greater than or equal to 500/mu L were followed for up to 11.5 years. HIV-1 RNA was measured from stored sera obtained a median of 7 months after the estimated seroconversion date. AIDS progression and mortality among the men were studied, stratified by median baseline levels of HIV-1 RNA. AIDS progression rates at 11.5 years were 69% and 34%, respectively, among those with higher versus lower than median baseline virus loads (greater than or equal to 3040 copies/mL; P=.002), and mortality rates were 61% and 27%, respectively (P=.003). Survival curves continued to diverge throughout the 11.5 years, suggesting that the future clinical course of HIV-1 infection may already be determined at the earliest phases of disease, Initiation of definitive treatment very early in HIV-1 infection may be essential.
引用
收藏
页码:798 / 800
页数:3
相关论文
共 10 条
[1]   TIME TO HIT HIV, EARLY AND HARD [J].
HO, DD .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :450-451
[2]   Viral counts count in HIV infection [J].
Ho, DD .
SCIENCE, 1996, 272 (5265) :1124-1125
[3]   A CONTROLLED TRIAL OF ZIDOVUDINE IN PRIMARY HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION [J].
KINLOCHDELOES, S ;
HIRSCHEL, BJ ;
HOEN, B ;
COOPER, DA ;
TINDALL, B ;
CARR, A ;
SAURAT, JH ;
CLUMECK, N ;
LAZZARIN, A ;
MATHIESEN, L ;
RAFFI, F ;
ANTUNES, F ;
VONOVERBECK, J ;
LUTHY, R ;
GLAUSER, M ;
HAWKINS, D ;
BAUMBERGER, C ;
YERLY, S ;
PERNEGER, TV ;
PERRIN, L .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (07) :408-413
[4]  
MARKOWITZ M, 1996, 11 INT C AIDS VANC C
[5]   Prognosis in HIV-1 infection predicted by the quantity of virus in plasma [J].
Mellors, JW ;
Rinaldo, CR ;
Gupta, P ;
White, RM ;
Todd, JA ;
Kingsley, LA .
SCIENCE, 1996, 272 (5265) :1167-1170
[6]   QUANTITATION OF HIV-1 RNA IN PLASMA PREDICTS OUTCOME AFTER SEROCONVERSION [J].
MELLORS, JW ;
KINGSLEY, LA ;
RINALDO, CR ;
TODD, JA ;
HOO, BS ;
KOKKA, RP ;
GUPTA, P .
ANNALS OF INTERNAL MEDICINE, 1995, 122 (08) :573-579
[7]   Serum HIV-1 RNA levels and time to development of AIDS in the multicenter hemophilia cohort study [J].
OBrien, TR ;
Blattner, WA ;
Waters, D ;
Eyster, ME ;
Hilgartner, MW ;
Cohen, AR ;
Luban, N ;
Hatzakis, A ;
Aledort, LM ;
Rosenberg, PS ;
Miley, WJ ;
Kroner, BL ;
Goedert, JJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (02) :105-110
[8]   Changes in plasma HIV-1 RNA and CD4+ lymphocyte counts and the risk of progression to AIDS [J].
OBrien, WA ;
Hartigan, PM ;
Martin, D ;
Esinhart, J ;
Hill, A ;
Benoit, S ;
Rubin, M ;
Lahart, C ;
Wray, N ;
Finegold, SM ;
George, WL ;
Dickinson, GM ;
Klimas, N ;
Diamond, G ;
ZollaPazner, SB ;
Jensen, PC ;
Hawkes, C ;
Oster, C ;
Gordin, F ;
Labriola, AM ;
Spivey, P ;
Matthews, T ;
Weinhold, K ;
Drusano, G ;
Egorin, MJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (07) :426-431
[9]   HIV-1 MESSENGER-RNA IN PERIPHERAL-BLOOD MONONUCLEAR-CELLS AS AN EARLY MARKER OF RISK FOR PROGRESSION TO AIDS [J].
SAKSELA, K ;
STEVENS, CE ;
RUBINSTEIN, P ;
TAYLOR, PE ;
BALTIMORE, D .
ANNALS OF INTERNAL MEDICINE, 1995, 123 (09) :641-+
[10]   PROGRESSION TO AIDS AND PREDICTORS OF AIDS IN SEROPREVALENT AND SEROINCIDENT COHORTS OF HOMOSEXUAL MEN [J].
SCHECHTER, MT ;
CRAIB, KJP ;
LE, TN ;
WILLOUGHBY, B ;
DOUGLAS, B ;
SESTAK, P ;
MONTANER, JSG ;
WEAVER, MS ;
ELMSLIE, KD ;
OSHAUGHNESSY, MV .
AIDS, 1989, 3 (06) :347-353